TipRanks
Go Ultimate55% OFF

Dhanlaxmi Crop Science Ltd. (DHANLAXMI) AI Stock Analysis

IN:DHANLAXMI

Dhanlaxmi Crop Science Ltd.

(NSE:DHANLAXMI)

Select Model
Rating:45Neutral
Action:reiterated
Date:09/06/26

The score is driven primarily by weakened financial performance: FY2026 profitability deteriorated sharply and multi-year negative operating/free cash flow increases near-term risk despite improved leverage. Valuation is also constrained by a negative P/E, while technical factors could not be evaluated from the provided indicators.

Positive Factors
Improved leverageThe sharp reduction in debt-to-equity materially lowers balance-sheet risk compared with FY2022 and should provide more flexibility to manage operations or fund opportunities. Moderate leverage is a durable financial cushion, even though weaker profitability reduces the benefit of that cushion.
Negative Factors
FY2026 earnings reversalThe latest-year deterioration weakens confidence in near-term earnings durability: revenue contracted after two years of strong growth, operating profitability compressed sharply, and net income became negative. Sustained losses could limit reinvestment capacity and make recovery dependent on improved execution.

Dhanlaxmi Crop Science Ltd. Business Overview & Revenue Model

Company Description

Dhanlaxmi Crop Science Ltd. is an Indian enterprise specializing in the manufacture and processing of agricultural seeds. Established in 1994 and based in Himatnagar, India, the company boasts a comprehensive portfolio of crop and vegetable seeds. Th...

How the Company Makes Money

null

Dhanlaxmi Crop Science Ltd. Financial Statement Overview

Summary

Financial quality is mixed and recently deteriorated. While leverage improved meaningfully (healthier debt-to-equity in FY2023–FY2026), FY2026 showed a sharp operational reversal with margin compression and net losses, and cash flow is a major concern with operating cash flow and free cash flow negative for multiple recent years.

Income Statement

46Neutral

Balance Sheet

64Positive

Cash Flow

24Negative
Financial statement breakdown
BreakdownTTMMar 2025Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue381.43M1.29B381.29M637.10M466.11M354.31M
Gross Profit145.15M208.60M85.50M121.98M85.64M55.26M
EBITDA81.28M126.13M10.40M68.78M44.94M15.32M
Net Income50.96M86.80M-4.92M46.78M29.95M5.83M
Balance Sheet
Total Assets760.13M829.16M638.44M349.62M200.27M208.63M
Cash, Cash Equivalents and Short-Term Investments3.45M138.89M14.03M10.99M32.27M14.38M
Total Debt111.29M71.72M105.82M10.42M25.83M91.32M
Total Liabilities254.39M369.78M183.97M188.41M86.31M146.91M
Stockholders Equity505.74M459.38M454.46M161.21M113.96M61.73M
Cash Flow
Free Cash Flow-244.22M-141.43M-158.84M-3.82M62.80M20.29M
Operating Cash Flow-217.16M-123.11M-146.55M827.00K62.98M20.29M
Investing Cash Flow-24.19M-15.38M-12.42M-4.63M-9,0002,000
Financing Cash Flow242.50M266.39M34.10M-17.48M-45.08M-12.02M

Dhanlaxmi Crop Science Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:DHANLAXMI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:GODREJAGROIN:GODREJAGRO72OutperformINR 106.57B23.82―1.99%8.58%-1.86%
IN:GOKULAGROIN:GOKULAGRO65NeutralINR 63.44B13.60――21.04%59.07%
IN:KSCLIN:KSCL64NeutralINR 34.15B13.37―1.51%-2.82%-16.45%
IN:INSECTICIDIN:INSECTICID58NeutralINR 15.10B11.82―0.39%1.26%-16.43%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:DHANLAXMIIN:DHANLAXMI45Neutral―-91.67――――

* General Sector Average

Performance Comparison

-50%-25%0%25%50%IN:CONTIIN:GODREJAGROIN:GOKULAGROIN:INSECTICIDIN:KSCLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:DHANLAXMI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:CONTIContinental Seeds & Chemicals Ltd.9.85-12.60-56.12%
IN:GODREJAGROGodrej Agrovet Limited553.85-94.65-14.59%
IN:GOKULAGROGokul Agro Resources Ltd.215.0047.3028.21%
IN:INSECTICIDInsecticides (India) Limited519.10-200.11-27.82%
IN:KSCLKaveri Seed Co. Ltd.663.80-362.21-35.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026